A transatlantic partnership between US healthcare provider Northwell Health, a United States-based healthcare and safety services organisation, and Enterprise Ireland is set to expand the commercial reach of Irish health and safety and medtech firms in the US, according to Business Plus.

The agreement focuses on scaling safety-critical technologies into clinical environments where compliance, patient protection, and operational risk management are central. It builds on a collaboration that began in 2016.

Northwell Health is already working with 18 Enterprise Ireland-backed companies. The partnership has enabled procurement contracts, clinical trials, and venture-backed investment across its network.

Access to 28 hospitals and more than 1,000 outpatient facilities provides Irish firms with infrastructure to test and deploy health and safety technologies at scale. This supports validation in regulated settings where safety and performance are closely monitored.

The agreement also includes a new partnership with Galway-based Neurent Medical, which is developing minimally invasive treatments for chronic rhinitis. The company recently raised €62.5m in an oversubscribed Series C funding round as it expands in the US.

Minister for Enterprise Peter Burke said the partnership offers Irish firms a “critical gateway” into the US healthcare system. He noted continued growth in Ireland’s life sciences sector, supported by research and development capability.

Northwell’s executive director of global strategic partnerships, Elaine Brennan, said the organisation’s international programme has helped Irish companies establish themselves in the US through pilot programmes and investment.

Enterprise Ireland executive director Kevin Sherry said the deal reflects the strength of Ireland’s R&D ecosystem, pointing to €491m in life sciences and healthtech venture capital investment in 2024 despite global funding pressures.

The partnership aligns with broader expansion by Irish healthcare companies in the US through new operations, clinical partnerships, and distribution agreements. 

Read the full report to see how the collaboration is shaping the future of health and safety innovation.